Atrial Fibrillation (AFIB) in the ICU: Incidence, Risk Factors, and Outcomes: The International AFIB-ICU Cohort Study von Wetterslev, Mik, Hylander Møller, Morten, Granholm, Anders, Hassager, Christian, Haase, Nicolai, Lange, Theis, Myatra, Sheila N., Hästbacka, Johanna, Arabi, Yaseen M., Shen, Jiawei, Cronhjort, Maria, Lindqvist, Elin, Aneman, Anders, Young, Paul J., Szczeklik, Wojciech, Siegemund, Martin, Koster, Thijs, Aslam, Tayyba Naz, Bestle, Morten H., Girkov, Mia S., Kalvit, Kushal, Mohanty, Rakesh, Mascarenhas, Joanne, Pattnaik, Manoranjan, Vergis, Sara, Haranath, Sai Praveen, Shah, Mehul, Joshi, Ziyokov, Wilkman, Erika, Reinikainen, Matti, Lehto, Pasi, Jalkanen, Ville, Pulkkinen, Anni, An, Youzhong, Wang, Guoxing, Huang, Lei, Huang, Bin, Liu, Wei, Gao, Hengbo, Dou, Lin, Li, Shuangling, Yang, Wanchun, Tegnell, Emily, Knight, Agnes, Czuczwar, Miroslaw, Czarnik, Tomasz, Perner, Anders

Volltext

Investigation of MGMT and DAPK1 methylation patterns in diffuse large B-cell lymphoma using allelic MSP-pyrosequencing von Kristensen, Lasse Sommer, Treppendahl, Marianne Bach, Asmar, Fazila, Girkov, Mia Seremet, Nielsen, Helene Myrtue, Kjeldsen, Tina Ellegaard, Ralfkiaer, Elisabeth, Hansen, Lise Lotte, Grønbæk, Kirsten

Volltext

Abstract B28: Investigation of MGMT methylation patterns in diffuse large B-cell lymphoma using a novel allelic methylation-specific PCR pyrosequencing assay von Kristensen, Lasse Sommer, Treppendahl, Marianne Bach, Girkov, Mia Seremet, Asmar, Fazila, Nielsen, Helene Myrtue, Kjeldsen, Tina, Ralfkiaer, Elisabeth, Hansen, Lise Lotte, Grønbæk, Kirsten

Volltext

TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy von Munch-Petersen, Helga D, Asmar, Fazila, Dimopoulos, Konstantinos, Areškevičiūtė, Aušrinė, Brown, Peter, Girkov, Mia Seremet, Pedersen, Anja, Sjö, Lene D, Heegaard, Steffen, Broholm, Helle, Kristensen, Lasse S, Ralfkiaer, Elisabeth, Grønbæk, Kirsten

Volltext

Additional file 1: of TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy von Munch-Petersen, Helga, Asmar, Fazila, Dimopoulos, Konstantinos, Aušrinė Areškevičiūtė, Brown, Peter, Girkov, Mia, Pedersen, Anja, Sjö, Lene, Heegaard, Steffen, Broholm, Helle, Kristensen, Lasse, Ralfkiaer, Elisabeth, Grønbæk, Kirsten

Volltext bestellen

Additional file 4: of TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy von Munch-Petersen, Helga, Asmar, Fazila, Dimopoulos, Konstantinos, Aušrinė Areškevičiūtė, Brown, Peter, Girkov, Mia, Pedersen, Anja, Sjö, Lene, Heegaard, Steffen, Broholm, Helle, Kristensen, Lasse, Ralfkiaer, Elisabeth, Grønbæk, Kirsten

Volltext bestellen

Additional file 3: Figure S1a-c. of TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy von Munch-Petersen, Helga, Asmar, Fazila, Dimopoulos, Konstantinos, Aušrinė Areškevičiūtė, Brown, Peter, Girkov, Mia, Pedersen, Anja, Sjö, Lene, Heegaard, Steffen, Broholm, Helle, Kristensen, Lasse, Ralfkiaer, Elisabeth, Grønbæk, Kirsten

Volltext bestellen

Additional file 2: Tables S1a-d. of TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy von Munch-Petersen, Helga, Asmar, Fazila, Dimopoulos, Konstantinos, Aušrinė Areškevičiūtė, Brown, Peter, Girkov, Mia, Pedersen, Anja, Sjö, Lene, Heegaard, Steffen, Broholm, Helle, Kristensen, Lasse, Ralfkiaer, Elisabeth, Grønbæk, Kirsten

Volltext bestellen